{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:53:34Z","timestamp":1787162014362,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"MINECO","award":["SAF2016-77241-R"],"award-info":[{"award-number":["SAF2016-77241-R"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12094-019-02064-4","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T07:09:44Z","timestamp":1550560184000},"page":"1348-1356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mitotic rate as an important prognostic factor in cutaneous malignant melanoma"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-8318","authenticated-orcid":false,"given":"A.","family":"Pi\u00f1ero-Madrona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ruiz-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cerezuela Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mart\u00ednez-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. N.","family":"Rodr\u00edguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cabezas-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"2064_CR1","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th edition. New York: Springer; 2010."},{"key":"2064_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00432-015-2007-1","volume":"142","author":"A Caldarella","year":"2016","unstructured":"Caldarella A, Fancelli L, Manneschi G, et al. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population based study. J Cancer Res Clin Oncol. 2016;142:73\u20136.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2064_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/bjd.12898","volume":"170","author":"AC Waal de","year":"2014","unstructured":"de Waal AC, van Harten-Gerritsen AS, Aben KK, et al. Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma. Br J Dermatol. 2014;170:874\u20137.","journal-title":"Br J Dermatol"},{"key":"2064_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.canep.2011.11.003","volume":"36","author":"G Ponti","year":"2012","unstructured":"Ponti G, Pollio A, Cesinaro AM, et al. Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients. Cancer Epidemiol. 2012;36:303\u20135.","journal-title":"Cancer Epidemiol"},{"key":"2064_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/cup.12517","volume":"42","author":"AR Lardon","year":"2015","unstructured":"Lardon AR, Rothschild B, Walls AC, et al. Impact of the 2009 AJCC staging guidelines for melanoma on the number of mitotic figures reported by dermatopathologists al one institution. J Cutan Pathol. 2015;42:536\u201341.","journal-title":"J Cutan Pathol"},{"key":"2064_CR6","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","volume":"29","author":"JF Thompson","year":"2011","unstructured":"Thompson JF, Soong SJ, Balch CM, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol. 2011;29:2199\u2013205.","journal-title":"J Clin Oncol"},{"key":"2064_CR7","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma of the skin, chapter 4. In: Amin MB, Edge SB, Greene FL, et al., editors. AJCC Cancer Staging Manual.  8th edition. Cham: Springer International Publishing AG; 2017. p. 563\u2013585."},{"key":"2064_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1245\/ASO.2004.07.014","volume":"11","author":"AB Francken","year":"2004","unstructured":"Francken AB, Shaw HM, Thompson JF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol. 2004;11:426\u201333.","journal-title":"Ann Surg Oncol"},{"key":"2064_CR9","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1200\/JCO.2013.54.2340","volume":"32","author":"A Maurichi","year":"2014","unstructured":"Maurichi A, Miceli R, Camerini T, et al. Prediction of survival in patients with thin melanoma: results from a multiinstitution study. J Clin Oncol. 2014;32:2479\u201385.","journal-title":"J Clin Oncol"},{"key":"2064_CR10","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1245\/s10434-010-1078-0","volume":"17","author":"R Murali","year":"2010","unstructured":"Murali R, Moncrieff MD, Hong J, Cooper CL, Shingde MV, Samuel DG, Thompson JF, Scolyer RA. The prognostic value of tumor mitotic rate and other clinicopathologic factors in patients with locoregional recurrences of melanoma. Ann Surg Oncol. 2010;17:2922\u201399.","journal-title":"Ann Surg Oncol"},{"key":"2064_CR11","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1200\/JCO.2005.02.0735","volume":"23","author":"PA Gimotty","year":"2005","unstructured":"Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guery D. Biologic and prognostic significance of dermal ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. J Clin Oncol. 2005;23:8048\u201356.","journal-title":"J Clin Oncol"},{"key":"2064_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.0303-6987.2005.00310.x","volume":"32","author":"RL Barnhill","year":"2005","unstructured":"Barnhill RL, Katzen J, Spatz A, Fine J, Berwick M. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol. 2005;32:268\u201373.","journal-title":"J Cutan Pathol"},{"key":"2064_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1529-8019.2005.00044.x","volume":"18","author":"DE Elder","year":"2005","unstructured":"Elder DE, Gimotty PA, Guerry D. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features. Dermatol Ther. 2005;18:369\u201385.","journal-title":"Dermatol Ther"},{"key":"2064_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.amjsurg.2012.11.012","volume":"206","author":"RA Scolyer","year":"2013","unstructured":"Scolyer RA, Thompson JF. Mitotic rate in melanoma should be recorded as the number of mitosis per mm2 (not per high power field): surgeons tell your pathologists! Am J Surg. 2013;206:142\u20133.","journal-title":"Am J Surg"},{"key":"2064_CR15","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1097\/00000478-200312000-00011","volume":"27","author":"RA Scolyer","year":"2003","unstructured":"Scolyer RA, Shaw HM, Thompson JF, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol. 2003;27:1571\u20136.","journal-title":"Am J Surg Pathol"},{"key":"2064_CR16","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1200\/JCO.2009.27.1627","volume":"28","author":"CM Balch","year":"2010","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, Cascinelli N, Cochran AJ, et al. Multivariate analysis of prognostic factors amon 2,313 patients with stage III melanoma: comparison of nodal micrometastases and macrometastases. J Clin Oncol. 2010;28:2452\u20139.","journal-title":"J Clin Oncol"},{"key":"2064_CR17","unstructured":"National Comprehensive Cancer Network: NCCN Guidelines\u00ae Version 2.2016: Melanoma NCCN Evidence Blocks\u2122. p. ME-3."},{"key":"2064_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/cam4.1320","volume":"7","author":"K Namikawa","year":"2018","unstructured":"Namikawa K, Aung PP, Gershenwald JE, Milton DR, Prieto VG. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study al a comprehensive cancer center. Cancer Med. 2018;7:583\u201393.","journal-title":"Cancer Med"},{"key":"2064_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.surg.2018.04.016","volume":"164","author":"JL Evans","year":"2018","unstructured":"Evans JL, Vidri RJ, MacGillivray DC, Fitzgerald TL. Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma. Surgery. 2018;164:589\u201393.","journal-title":"Surgery"},{"key":"2064_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1245\/ASO.2005.04.027","volume":"12","author":"SB Kesmodel","year":"2005","unstructured":"Kesmodel SB, Karakousis GC, Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol. 2005;12:449\u201358.","journal-title":"Ann Surg Oncol"},{"key":"2064_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jaad.2015.07.007","volume":"73","author":"K Ottmann","year":"2015","unstructured":"Ottmann K, Tronnier M, Mitteldorf C. Detection of mitotic figures in thin melanomas: immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin\u2013eosin stain. J Am Acad Dermatol. 2015;73:637\u201344.","journal-title":"J Am Acad Dermatol"},{"key":"2064_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamasurg.2014.3843","volume":"150","author":"S Lou","year":"2015","unstructured":"Lou S, Lobo AZC, Tanabe KK, Muzikansky A, Durazzo T, Sober A, Tsao H, Osimi B, Lawrence DP, Duncan LM. Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes. JAMA Surg. 2015;150:465\u201372.","journal-title":"JAMA Surg"},{"key":"2064_CR23","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","volume":"31","author":"D Han","year":"2013","unstructured":"Han D, Zager JS, Shyr Y, et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol. 2013;31:4387\u201393.","journal-title":"J Clin Oncol"},{"key":"2064_CR24","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1245\/s10434-014-4349-3","volume":"22","author":"MJ Speijers","year":"2015","unstructured":"Speijers MJ, Bastiaannet E, Sloot S et al. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? A single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Ann Surg Oncol. 2015;22:2978\u201387.","journal-title":"Ann Surg Oncol"},{"key":"2064_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaad.2015.09.014","volume":"74","author":"H Wat","year":"2016","unstructured":"Wat H, Senthiselvan A, Salopek TG. A retrospective multicenter analysis of the predictive value of mitotic rate for sentinel lymph node positivity in thin melanoma. J Am Acad Dermatol. 2016;74:94\u2013101.","journal-title":"J Am Acad Dermatol"},{"key":"2064_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.11.041","author":"L Wheless","year":"2017","unstructured":"Wheless L, Isom CA, Hooks MA, Kauffmann RM. Mitotic rate is associated with positive lymph nodes in thin melanoma. J Am Acad Dermatol. 2017. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2017.11.041\n                    \n                  .","journal-title":"J Am Acad Dermatol"},{"key":"2064_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/jso.23880","volume":"111","author":"JJ Baker","year":"2015","unstructured":"Baker JJ, Meyers MO, Deal AM, et al. Prognostic significance of tumor mitotic rate in T2 melanoma staged with sentinel lymphadenectomy. J Surg Oncol. 2015;111:711\u20135.","journal-title":"J Surg Oncol"},{"key":"2064_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.amjsurg.2015.05.016","volume":"211","author":"A Kibrit\u00e9","year":"2016","unstructured":"Kibrit\u00e9 A, Milot H, Douville P, et al. Predictive factors for sentinel lymph nodes and non-sentinel lymph nodes metastatic involvement: a database study of 1041 melanoma patients. Am J Surg. 2016;211:89\u201394.","journal-title":"Am J Surg"},{"key":"2064_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/01.DSS.0000452619.94264.ff","volume":"40","author":"EB Kirkland","year":"2014","unstructured":"Kirkland EB, Zitelli JA. Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy? Dermatol Surg. 2014;40:937\u201345.","journal-title":"Dermatol Surg"},{"key":"2064_CR30","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/jdv.12395","volume":"28","author":"R Betti","year":"2014","unstructured":"Betti R, Santambrogio R, Cerri A, et al. Observational study on the mitotic rate and other prognostic factors in cutaneous primary melanoma arising from naevi and from melanoma de novo. J Eur Acad Dermatol Venereol. 2014;28:1736\u201341.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2064_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jso.24503","volume":"115","author":"PD Lorimer","year":"2017","unstructured":"Lorimer PD, Benham EC, Walsh K, et al. Reporting of mitotic rate in cutaneous melanoma: a study usnig the national cancer data base. J Surg Oncol. 2017;115:281\u20136.","journal-title":"J Surg Oncol"},{"key":"2064_CR32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/jso.24738","volume":"116","author":"L Roncati","year":"2017","unstructured":"Roncati L, Piscioli F, Pusiol T. The importance of mitotic rate reporting in primary cutaneous melanoma. J Surg Oncol. 2017;116:958\u20139.","journal-title":"J Surg Oncol"},{"key":"2064_CR33","first-page":"2025","volume":"31","author":"A Tejera-Vaquerizo","year":"2017","unstructured":"Tejera-Vaquerizo A, P\u00e9rez-Cabello G, Mart\u00ednez-Leborans L, et al. Is mitotic rate still useful in the management with thin melanoma? JEADV. 2017;31:2025\u20139.","journal-title":"JEADV"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-019-02064-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-019-02064-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:06:35Z","timestamp":1582052795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-019-02064-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1007\/s12094-019-02064-4","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"19 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It was reviewed and approved by the IRB as an observational retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As non-interventional retrospective study consent is not required for this type of study. The management of all data was anonymous and dissociated.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}